Fig. 2From: Cost-effectiveness analysis of systematic fast-track transition from oncological treatment to specialised palliative care at home for patients and their caregivers: the DOMUS trialUtility scores on the EORTC QLQ-C30 for patients and SF-36 for caregivers. Note: Actual summary scores and the mapped utility scores are shown in Additional file 2. *2 weeks and 2 months after death is not necessarily after 6 months Source: DOMUS trial data. EORTC QLQ-C30 for patients and SF-36 for caregiversBack to article page